Tirzepatide is the weekly shot Eli Lilly sells as Zepbound for weight loss and as Mounjaro for type 2 diabetes. Zepbound costs from $299 a month at 2.5 mg from LillyDirect, and compounded tirzepatide from $69 a month at Collective (drug price, plus a yearly membership), prices checked November 16, 2026.
No insurance needed. Two programs to check.
Eden$129 a monthWeight loss warranty includedCheck price →
Collective$69 a month, drug price21-day membership trialCheck price →
Tirzepatide by brand name
| Brand | Approved for | How you take it | Lowest cash price |
|---|---|---|---|
| Zepbound Eli Lilly. Vial or KwikPen | Adults with obesity (BMI 30 or more), or overweight (BMI 27 or more) with at least one weight-related condition, alongside diet and exercise. Also moderate to severe obstructive sleep apnea in adults with obesity | Once a week. 2.5 mg for 4 weeks, up to 15 mg weekly | $299 at 2.5 mg, $399 at 5 mg, then $449 at 7.5 mg to 15 mg if you refill within 45 days, otherwise $499 at 7.5 mg and $699 at 10 mg to 15 mg, from LillyDirect |
| Mounjaro Eli Lilly. Injection pen | People with type 2 diabetes, to lower blood sugar. Use for weight loss alone is off-label | Once a week. 2.5 mg once weekly, up to 15 mg in adults | $499 a month, from LillyDirect |
| Compounded tirzepatide A licensed pharmacy. Vial | Not reviewed by the FDA. Prescribed for the same uses as Zepbound | Once a week. Programs usually follow the Zepbound steps, starting at 2.5 mg and rising every 4 weeks | From $69 a month at Collective (drug price, plus a yearly membership), or $129 a month at Eden with no yearly membership |
Cash prices are the sellers' own, checked November 16, 2026. You need a prescription for every row.
What tirzepatide does
Tirzepatide acts on the receptors for two hormones your gut makes after a meal, GLP-1 and GIP. Most drugs in the class act on GLP-1 alone. The Zepbound label says it lowers appetite and food intake and slows how fast the stomach empties.
Eli Lilly owns it and sells it under two brand names. The label decides which one you get. Zepbound is approved for weight loss, and also for sleep apnea in adults with obesity. Mounjaro is approved for type 2 diabetes, so a plan may pay for it only with that diagnosis.
Dose steps and what each one costs
The Zepbound label starts at 2.5 mg for 4 weeks and moves to 5 mg after 4 weeks, then 2.5 mg increments after at least 4 weeks on the current dose. It names 5 mg, 10 mg or 15 mg as the doses to stay on, up to 15 mg weekly.
LillyDirect charges by dose for Zepbound vials and the KwikPen: $299 at 2.5 mg, $399 at 5 mg, then $449 at 7.5 mg to 15 mg if you refill within 45 days, otherwise $499 at 7.5 mg and $699 at 10 mg to 15 mg. Mounjaro has one self-pay price at LillyDirect, $499 a month. The steps by week are on Zepbound dosing.
How much weight people lost on it
In SURMOUNT-1, 2,539 adults with obesity or overweight and no type 2 diabetes took tirzepatide or a placebo once a week for 72 weeks. Average weight loss was 15 percent at 5 mg, 19.5 percent at 10 mg, 20.9 percent at 15 mg. The placebo group lost 3.1 percent.
Against semaglutide in a head-to-head trial, tirzepatide took off more weight. The figures and the cost of each are on tirzepatide vs semaglutide cost.
Compounded tirzepatide
Telehealth programs also sell tirzepatide made by a licensed pharmacy against a prescription. The FDA has not approved it and does not check it before it is sold. No trial tested the compounded product. It costs from $69 a month at Collective (drug price, plus a yearly membership), or $129 a month at Eden with no yearly membership.
Every program and its price is on tirzepatide cost, and the compounded dose steps are on compounded tirzepatide dosing.
Questions people ask
What is the brand name for tirzepatide?
Is tirzepatide a GLP-1?
How much weight do people lose on tirzepatide?
Is compounded tirzepatide the real thing?
Read next
- What is semaglutide?
- Weight loss injections, cheapest first
- Mounjaro vs Zepbound
- Every GLP-1 medication side by side
Sources
Evidence checked November 15, 2026
Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.
4 documents
- Zepbound's approved uses, its dose steps and how tirzepatide worksFDA prescribing information for Zepbound (DailyMed, revised August 2026)
- Mounjaro's approved use and its dose stepsFDA prescribing information for Mounjaro (DailyMed, revised August 2026)
- SURMOUNT-1: weight loss at each dose over 72 weeks against placeboSURMOUNT-1, Jastreboff AM et al. N Engl J Med 2022;387(3):205-216
- The FDA has not approved compounded drugs and does not review them before they are soldFDA's concerns with unapproved GLP-1 drugs used for weight loss (FDA)
Prices from the programs' own pages, NovoCare and LillyDirect, checked November 16. How we check prices.